Sacubitril/Valsartan Improves Diastolic Function But Not Skeletal Muscle Function in a Rat Model of HFpEF

Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction

(2020) Isabel T. N. Nguyen et al.   PLoS One

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial

(2020) Rolf Wachter et al.   ESC Heart Failure

Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF

(2020) Jonathan W. Cunningham et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction

(2020) Antje Schauer et al.   ESC Heart Failure

Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure

(2020) Michele Emdin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

C-type natriuretic peptide moderates titin-based cardiomyocyte stiffness

(2020) Konstanze Michel et al.   JCI Insight

Muscular changes in animal models of heart failure with preserved ejection fraction: what comes closest to the patient?

(2020) Keita Goto et al.   ESC Heart Failure

Angiotensin Receptor Neprilysin Inhibitor for Functional Mitral Regurgitation: The PRIME Study

(2019) Duk-Hyun Kang et al.   CIRCULATION

Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction

(2019) Sara Leite et al.   Circulation-Heart Failure

Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction

(2019) Scott D. Solomon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Sacubitril-Valsartan, versus Valsartan, in Women Compared to Men with Heart Failure and Preserved Ejection Fraction: Insights from PARAGON-HF

(2019) John J. V. McMurray et al.   CIRCULATION

Myocardial adipose deposition and the development of heart failure with preserved ejection fraction

(2019) Cho‐Kai Wu et al.   EUROPEAN JOURNAL OF HEART FAILURE

Endothelial function is disturbed in a hypertensive diabetic animal model of HFpEF: Moderate continuous vs. high intensity interval training

(2018) Zelia Schmederer et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Neprilysin inhibition in heart failure: mechanisms and substrates beyond modulating natriuretic peptides

(2017) Emilia D'Elia et al.   EUROPEAN JOURNAL OF HEART FAILURE

The effect of beta-blockers on mortality in heart failure with preserved ejection fraction: A meta-analysis of observational cohort and randomized controlled studies

(2017) Hidekatsu Fukuta et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial

(2017) Jelena P Seferovic et al.   Lancet Diabetes & Endocrinology

Angiotensin Receptor Neprilysin Inhibition in Heart Failure With Preserved Ejection Fraction

(2017) Scott D. Solomon et al.   JACC-Heart Failure

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice

(2016) Yasunori Suematsu et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction

(2016) Dalane W. Kitzman et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Animal models of heart failure with preserved ejection fraction

(2016) G. Conceição et al.   Netherlands Heart Journal

Is enhancing cGMP-PKG signalling a promising therapeutic target for heart failure with preserved ejection fraction?

(2016) Á. Kovács et al.   Netherlands Heart Journal

Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction

(2016) Constantijn Franssen et al.   JACC-Heart Failure

Multimodal Imaging Spectroscopy of Tissue

(2015) Nadine Vogler et al.   Annual Review of Analytical Chemistry

Effects of renin–angiotensin–aldosterone system inhibitors on mortality, hospitalization, and diastolic function in patients with HFpEF

(2015) Q. Zhang et al.   HERZ

Spironolactone for Heart Failure with Preserved Ejection Fraction

(2014) Bertram Pitt et al.   NEW ENGLAND JOURNAL OF MEDICINE

Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model

(2013) Nazha Hamdani et al.   Circulation-Heart Failure

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

(2013) Walter J. Paulus et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Protein conformation and molecular order probed by second-harmonic-generation microscopy

(2012) Francesco Vanzi   JOURNAL OF BIOMEDICAL OPTICS

Coronary perivascular fibrosis is associated with impairment of coronary blood flow in patients with non-ischemic heart failure

(2012) Zhehao Dai et al.   Journal of Cardiology

Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy

(2011) John Paul Pezacki et al.   Nature Chemical Biology

Epidemiology and clinical course of heart failure with preserved ejection fraction

(2010) Carolyn S.P. Lam et al.   EUROPEAN JOURNAL OF HEART FAILURE

Protein Kinase G Modulates Human Myocardial Passive Stiffness by Phosphorylation of the Titin Springs

(2008) Martina Krüger et al.   CIRCULATION RESEARCH

Measurement of cardiac function using pressure–volume conductance catheter technique in mice and rats

(2008) Pál Pacher et al.   Nature Protocols